Although oral cholera vaccines exist, the recent spike in cases and limited production capacity have outpaced the global vaccine supply, prompting researchers to explore alternative protection ...
Crofelemer previously granted orphan-drug designation by the FDA and the European Medicines Agency (EMA) for both short bowel syndrome and microvillus inclusion disease SAN FRANCISCO, CA / ACCESSWIRE ...
As cholera continues to surge — and as vaccines remain in short supply — experts are warning about the global risk. Cholera is a bacterial disease typically spread by food and water, leading to severe ...
SAN FRANCISCO, CA / ACCESSWIRE / December 17, 2024 / Jaguar Health (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) today announced that the U.S. Food and Drug Administration (FDA) ...
World Health Organization (WHO) has classified the global resurgence of cholera at the highest internal level for emergencies; 1.3 to 4 million cholera cases and 21,000 to 143,000 cholera-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results